Why the study?
Is left ventricular hypertrophy associated with increased infarct size and worse clinical outcomes in STEMI patients undergoing primary PCI?
Is left ventricular hypertrophy associated with increased infarct size and worse clinical outcomes in STEMI patients undergoing primary PCI?
In STEMI patients undergoing primary PCI, baseline left ventricular hypertrophy is independently associated with larger infarct size, reduced myocardial salvage, and a higher risk of mortality and heart failure readmission.
Answers are grounded in this paper and cite their sources.
LVH association with larger infarcts and mortality in STEMI is hypothesis-generating; leaves open causality and therapeutic targeting.
BACKGROUND: Approximately one third of patients with ST-segment elevation myocardial infarction (STEMI) have left ventricular hypertrophy (LVH), which is associated with impaired outcome. However, the causal association between LVH and outcome in STEMI is unknown. We evaluated the association between LVH and: myocardial infarct size, area at risk, myocardial salvage, microvascular obstruction, left ventricular (LV) function (all determined by cardiac magnetic resonance [CMR]), and all-cause mortality and readmission for heart failure in STEMI patients treated with primary percutaneous coronary intervention. METHODS AND RESULTS: (women). One hundred seventy-eight patients (24%) had LVH. LVH was associated with a larger final infarct size (15% [interquartile range {IQR}, 10-21] vs 9% [IQR, 3-17]; P<0.001) and smaller final myocardial salvage index (0.6 [IQR, 0.5-0.7] vs 0.7 [IQR, 0.5-0.9]; P<0.001). The LVH group had a higher incidence of microvascular obstruction (66% vs 45%; P<0.001) and lower final LV ejection fraction (LVEF; 53% [IQR, 47-60] vs 61% [IQR, 55-65]; P<0.001). In a Cox regression analysis, LVH was associated with a higher risk of all-cause mortality and readmission for heart failure (hazard ratio 2.59 [95% CI, 1.38-4.90], P=0.003). The results remained statistically significant in multivariable models. CONCLUSIONS: LVH is independently associated with larger infarct size, less myocardial salvage, higher incidence of microvascular obstruction, lower LVEF, and a higher risk of all-cause mortality and incidence of heart failure in STEMI patients treated with primary percutaneous coronary intervention. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT01435408.
No takes yet. Share an insight, caveat, or question.
Nepper‐Christensen et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: